Linked Life Data

15598588

Source:http://linkedlifedata.com/resource/pubmed/id/15598588

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15598588rdf:typepubmed:Citationlld:pubmed
pubmed-article:15598588lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15598588lifeskim:mentionsumls-concept:C0034802lld:lifeskim
pubmed-article:15598588lifeskim:mentionsumls-concept:C0007137lld:lifeskim
pubmed-article:15598588lifeskim:mentionsumls-concept:C0078058lld:lifeskim
pubmed-article:15598588lifeskim:mentionsumls-concept:C0460004lld:lifeskim
pubmed-article:15598588lifeskim:mentionsumls-concept:C0079633lld:lifeskim
pubmed-article:15598588lifeskim:mentionsumls-concept:C0683149lld:lifeskim
pubmed-article:15598588lifeskim:mentionsumls-concept:C0751177lld:lifeskim
pubmed-article:15598588lifeskim:mentionsumls-concept:C0751688lld:lifeskim
pubmed-article:15598588lifeskim:mentionsumls-concept:C1171892lld:lifeskim
pubmed-article:15598588pubmed:issue1lld:pubmed
pubmed-article:15598588pubmed:dateCreated2004-12-15lld:pubmed
pubmed-article:15598588pubmed:abstractTextSquamous cell cancer of the head and neck (SCCHN) is associated with production of pro-inflammatory and pro-angiogenic cytokines. We hypothesized that cytokine serum levels will correlate with tumor volume and aggressiveness. We investigated interleukin-8 (IL-8), vascular endothelial growth factor (VEGF), and epidermal growth factor receptor (EGFR) in SCCHN. The patient population consisted of normal and irradiated controls: patients with newly diagnosed SCCHN, and patients with recurrent or metastatic disease. Pretreatment sera were studied by ELISA. Serum IL-8 levels, as opposed to VEGF or EGFR, were consistently elevated in patients with recurrent or metastatic disease. The differences in mean serum IL-8, compared to controls, were significant (p=0.02). Serum levels of IL-8 are consistently elevated in patients with recurrent or metastatic SCCHN and elevated levels may correlate with advanced or aggressive disease. Further, more intensive, study of IL-8 as a biomarker in SCCHN is warranted.lld:pubmed
pubmed-article:15598588pubmed:languageenglld:pubmed
pubmed-article:15598588pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15598588pubmed:citationSubsetIMlld:pubmed
pubmed-article:15598588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15598588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15598588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15598588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15598588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15598588pubmed:statusMEDLINElld:pubmed
pubmed-article:15598588pubmed:monthJanlld:pubmed
pubmed-article:15598588pubmed:issn1368-8375lld:pubmed
pubmed-article:15598588pubmed:authorpubmed-author:CavaciniLisa...lld:pubmed
pubmed-article:15598588pubmed:authorpubmed-author:PosnerMarshal...lld:pubmed
pubmed-article:15598588pubmed:authorpubmed-author:WirthLoriLlld:pubmed
pubmed-article:15598588pubmed:authorpubmed-author:HaddadRobert...lld:pubmed
pubmed-article:15598588pubmed:authorpubmed-author:WeeksLindaLlld:pubmed
pubmed-article:15598588pubmed:authorpubmed-author:FaucherJarrod...lld:pubmed
pubmed-article:15598588pubmed:authorpubmed-author:GokhaleAbhay...lld:pubmed
pubmed-article:15598588pubmed:authorpubmed-author:HallarMelissa...lld:pubmed
pubmed-article:15598588pubmed:issnTypePrintlld:pubmed
pubmed-article:15598588pubmed:volume41lld:pubmed
pubmed-article:15598588pubmed:ownerNLMlld:pubmed
pubmed-article:15598588pubmed:authorsCompleteYlld:pubmed
pubmed-article:15598588pubmed:pagination70-6lld:pubmed
pubmed-article:15598588pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:15598588pubmed:meshHeadingpubmed-meshheading:15598588...lld:pubmed
pubmed-article:15598588pubmed:meshHeadingpubmed-meshheading:15598588...lld:pubmed
pubmed-article:15598588pubmed:meshHeadingpubmed-meshheading:15598588...lld:pubmed
pubmed-article:15598588pubmed:meshHeadingpubmed-meshheading:15598588...lld:pubmed
pubmed-article:15598588pubmed:meshHeadingpubmed-meshheading:15598588...lld:pubmed
pubmed-article:15598588pubmed:meshHeadingpubmed-meshheading:15598588...lld:pubmed
pubmed-article:15598588pubmed:meshHeadingpubmed-meshheading:15598588...lld:pubmed
pubmed-article:15598588pubmed:meshHeadingpubmed-meshheading:15598588...lld:pubmed
pubmed-article:15598588pubmed:meshHeadingpubmed-meshheading:15598588...lld:pubmed
pubmed-article:15598588pubmed:meshHeadingpubmed-meshheading:15598588...lld:pubmed
pubmed-article:15598588pubmed:meshHeadingpubmed-meshheading:15598588...lld:pubmed
pubmed-article:15598588pubmed:meshHeadingpubmed-meshheading:15598588...lld:pubmed
pubmed-article:15598588pubmed:meshHeadingpubmed-meshheading:15598588...lld:pubmed
pubmed-article:15598588pubmed:meshHeadingpubmed-meshheading:15598588...lld:pubmed
pubmed-article:15598588pubmed:meshHeadingpubmed-meshheading:15598588...lld:pubmed
pubmed-article:15598588pubmed:year2005lld:pubmed
pubmed-article:15598588pubmed:articleTitleSerum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck.lld:pubmed
pubmed-article:15598588pubmed:affiliationHuman Monoclonal Antibody Laboratory, Division of Hematology-Oncology, Department of Medicine, Room 556, 21-27 Burlington Avenue, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.lld:pubmed
pubmed-article:15598588pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15598588lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15598588lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15598588lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15598588lld:pubmed